Global Small Animal Imaging (In-Vivo) Market (Technology, Applications and Geography) - Industry Analysis and Forecast, 2013 - 2020 is a new market research publication announced by Reportstack. Imaging modalities emerged as a preferred option for the clinical industry, especially in preclinical studies. Many of the imaging technologies have been...

Global Small Animal Imaging (In-Vivo) Market (Technology, Applications and Geography) - Industry Analysis and Forecast, 2013 - 2020 is a new market research publication announced by Reportstack. Imaging modalities emerged as a preferred option for the clinical industry, especially in preclinical studies. Many of the imaging technologies have been translated into micro level tools that include micro MRI, micro CT and micro PET. Apart from these technologies, micro ultrasound imaging, micro-magnetic resonance imaging (MRI), optical Imaging such as bioluminescence and fluorescence imaging, and multimodal imaging technologies have gained traction in the market. Rising number of the pre-clinical research, increasing investments by the CROs in the research activities, growing applications of multi-functional pre-clinical imaging and technological advancements such as high resolution multimodality MRI are the few factors impacting the global market positively. However, the stringent regulatory impositions coupled with inadequate reimbursement scenario would restrain the market growth to a certain extent. Despite of the aforementioned market restraints, commercialization of cost-efficient devices would ease the negative influence of restraints and fuel the market growth, primarily across the developing regions.

The market for small animal imaging (In-Vivo) is expected to reach at $2.1 billion by 2020. Rising number of Pharmaceutical companies and clinical research organizations, increasing applications of in-vivo imaging in pre-clinical research, real time data storage and high-resolution modalities, are the key growth factors of the market. Inadequate infrastructure provisions for research facilities, advanced instruments and the lack of skilled research personnel in emerging economies along with the requirement of high-end devices are likely to be the major restraints of small animal imaging (in-vivo) market. Going forward, the global clinical research initiatives, along with the development in technologies associated with pre-clinical trials will provide the platform for growth.

North America, dominates the market amongst all geographies owing to adoption of advanced technologies, healthcare awareness and favorable reimbursement policies. Geographically, about ~35 of the small animal imaging (in-vivo) market share is held by the North America owing to the heavy investments and affordability of advanced small animal in-vivo imaging devices in pre-clinical research. On the other hand, Asia-Pacific market would grow at the promising CAGR of 11.5% over the forecast period. Such high growth rate is majorly attributed towards untapped state of the market, hence would provide an opportunities for the small animal imaging devices manufacturers.